HBM4EU is a project funded under Horizon 2020 and runs from 2017 until 2021. It generates knowledge to inform about the safe management of chemicals, and hence protect human health in Europe. HBM4EU uses human biomonitoring (HBM) to monitor the actual human exposure to chemicals and resulting health impacts to build upon existing evidence bases and improve chemical risk assessment. HBM4EU compares data from across Europe which allows an understanding of regional differences and can help to identify vulnerable groups in order to inform targeted measures to reduce exposure. The results of the HBM4EU project are aimed at supporting policy development, by providing a key evidence base in the understanding of exposure and impacts to toxic chemic...
The European Human Biomonitoring Initiative (HBM4EU) is a project gathering 30 countries, funded und...
The Human Biomonitoring Initiative HBM4EU (https://www.hbm4eu.eu/the-project/) is a joint effort of ...
The aim of this work was to demonstrate how human biomonitoring (HBM) data can be included in differ...
Funding: This work has received external funding from the European Union’s Horizon 2020 research and...
This deliverable reports on the achievements of HBM4EU from 2017 until 2020 per substance group. The...
This deliverable reports on the achievements of HBM4EU in 2017 and 2018 per substance group. The res...
This deliverable is the final reporting on the achievements of HBM4EU from 2017 until 2022 per subst...
The use of chemicals in a wide range of products, from fields of application as varied as biomedicin...
The default approach in the risk assessment (RA) of chemicals is to assess external exposure by comb...
HBM4EU is a joint effort of 28 countries, the European Environment Agency and the European Commissio...
HBM4EU is a joint effort of 30 countries, the European Environment Agency and the European Commissio...
International audienceThe European Human Biomonitoring Initiative (HBM4EU1) has established a Europe...
The use of chemicals in a wide spectrum of applications from biomedicine to agriculture has brought ...
A major goal of the European Human Biomonitoring Initiative, HBM4EU, is to coordinate and advance hu...
International audienceHuman biomonitoring (HBM) is a crucial approach for exposure assessment, as em...
The European Human Biomonitoring Initiative (HBM4EU) is a project gathering 30 countries, funded und...
The Human Biomonitoring Initiative HBM4EU (https://www.hbm4eu.eu/the-project/) is a joint effort of ...
The aim of this work was to demonstrate how human biomonitoring (HBM) data can be included in differ...
Funding: This work has received external funding from the European Union’s Horizon 2020 research and...
This deliverable reports on the achievements of HBM4EU from 2017 until 2020 per substance group. The...
This deliverable reports on the achievements of HBM4EU in 2017 and 2018 per substance group. The res...
This deliverable is the final reporting on the achievements of HBM4EU from 2017 until 2022 per subst...
The use of chemicals in a wide range of products, from fields of application as varied as biomedicin...
The default approach in the risk assessment (RA) of chemicals is to assess external exposure by comb...
HBM4EU is a joint effort of 28 countries, the European Environment Agency and the European Commissio...
HBM4EU is a joint effort of 30 countries, the European Environment Agency and the European Commissio...
International audienceThe European Human Biomonitoring Initiative (HBM4EU1) has established a Europe...
The use of chemicals in a wide spectrum of applications from biomedicine to agriculture has brought ...
A major goal of the European Human Biomonitoring Initiative, HBM4EU, is to coordinate and advance hu...
International audienceHuman biomonitoring (HBM) is a crucial approach for exposure assessment, as em...
The European Human Biomonitoring Initiative (HBM4EU) is a project gathering 30 countries, funded und...
The Human Biomonitoring Initiative HBM4EU (https://www.hbm4eu.eu/the-project/) is a joint effort of ...
The aim of this work was to demonstrate how human biomonitoring (HBM) data can be included in differ...